Skip to main content
Leaving UL Solutions website
Within UL Solutions we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Approved/Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brand, we have processes in place to identify and manage any potential conflicts of interest and maintain impartiality. UL Solutions is unable to provide consultancy services to EU MDD, MDR or IVDD Notified Body, UKCA MD Approved Body or MDSAP Customers.
  • Feature Story

Minnesota Enacts Flame Retardants Prohibition

November 7, 2016

Minnesota Senate Bill S.F. 1215 prohibits the use of specified flame retardant chemicals in certain products. Beginning July 1, 2018, children’s products, upholstered residential furniture, residential textiles, and mattresses containing the following chemicals in amounts greater than 1,000 parts per million in any product component are prohibited from being manufactured, sold, offered for sale, or distributed for sale or use:

  • TDCPP (tris(1,3-dichloro-2-propyl)phosphate), CAS # 13674-87-8;
  • decabromodiphenyl ether, CAS # 1163-19-5;
  • hexabromocyclododecane, CAS # 25637-99-4; and
  • TCEP (tris(2-chloroethyl)phosphate), CAS # 115-96-8.

Beginning July 1, 2019, retailers are prohibited from selling or offering for sale or use any children’s products or upholstered residential furniture containing these same flame retardant chemicals in amounts greater than 1,000 parts per million in any product component.

 

Source